John Schoonbee on why new drugs, while helpful, are no panacea for obesity

Belgique Nouvelles Nouvelles

John Schoonbee on why new drugs, while helpful, are no panacea for obesity
Belgique Dernières Nouvelles,Belgique Actualités
  • 📰 TheEconomist
  • ⏱ Reading Time:
  • 55 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 25%
  • Publisher: 92%

Weight-loss drugs will change lives, writes Swiss Re’s chief medical officer in a guest essay. But they come “with strings attached”

have come on the market or are likely to be approved soon. From Big Pharma to biotechs, a bevy of firms are either selling such medicines or running trials.

Anyone thinking of taking these medicines needs to consider some important caveats. GLP-1 drugs come with side-effects that include nausea, dyspepsia, abdominal distension and reflux, though these often diminish over time. About 7% of people in one trial ended treatment because of side-effects, compared with 3.1% in the placebo group.

If these drugs are destined to be used by individuals for decades, side-effects are also likelier to accumulate. Lifelong treatments have big financial implications, too. The annual price of injections has been pegged at as much as $13,600 in AmericaEven if the price falls as competition intensifies, anti-obesity drugs could prove very costly for public insurance programmes, should they be required to cover them.

Two of the most important such interventions relate to what we eat and how much we exercise. Much of what we consume today looks nothing like what our ancestors put on their plates, skewed as it is towards processed food. Life is also growing more automated, meaning less physical labour and more sedentary lifestyles.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

TheEconomist /  🏆 6. in UK

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Sir Elton John Shares How He's Really Feeling After Ending His Farewell TourSir Elton John Shares How He's Really Feeling After Ending His Farewell TourThe music legend said he was still 'trying to process it' after his Farewell Yellow Brick Road tour finally came to an end.
Lire la suite »

Beats by Dre cost £155 less than Apple and John Lewis in Amazon Prime Day saleBeats by Dre cost £155 less than Apple and John Lewis in Amazon Prime Day sale'Great noise cancellation, sound quality is superb and the comfort over the ear is much better than in ear, actually helps the noise canceling.'
Lire la suite »

Emily Blunt talks 'guilt' over separation from daughters with John Krasinski and acting breakEmily Blunt talks 'guilt' over separation from daughters with John Krasinski and acting breakThe Oppenheimer star wants to be there to watch her daughters hit new milestones
Lire la suite »

Footage re-emerges of press punch-up after John McEnroe stormed out of press roomFootage re-emerges of press punch-up after John McEnroe stormed out of press roomFootage has re-emerged of a brawl between reporters following a prematurely-ended press conference involving tennis legend John McEnroe. The clip taken from the press room came after the Wimbledon …
Lire la suite »

Clare Balding's putdown as John McEnroe says 'inappropriate' jokeClare Balding's putdown as John McEnroe says 'inappropriate' jokeClare Balding stopped John McEnroe in his tracks
Lire la suite »

John McEnroe paid over £200k for Wimbledon punditry, more than Sue Barker's replacementJohn McEnroe paid over £200k for Wimbledon punditry, more than Sue Barker's replacementTennis legend John McEnroe is understood to be receiving between £205,000 – £209,000 by the BBC for his punditry during Wimbledon. The newly-released BBC salary report shows the three-time Wi…
Lire la suite »



Render Time: 2025-04-01 22:58:33